| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 7 | |
| #2 | Canada | 5 | |
| #3 | Australia | 4 | |
| #4 | Israel | 4 | |
| #5 | WIPO (World Intellectual Property Organization) | 4 | |
| #6 | Brazil | 2 | |
| #7 | Colombia | 2 | |
| #8 | China | 1 | |
| #9 | United Kingdom | 1 | |
| #10 | Mexico | 1 | |
| #11 | Philippines | 1 | |
| #12 | Singapore | 1 | |
| #13 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Heterocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Barchielli Marco | 15 |
| #2 | Graziani Davide | 13 |
| #3 | Riva Carlo | 13 |
| #4 | Colombo Paolo | 13 |
| #5 | Rossi Alessandra | 13 |
| #6 | Adorni Greta | 12 |
| #7 | Angelico Patrizia | 12 |
| #8 | Longhi Matteo | 8 |
| #9 | Callegari Elisa | 8 |
| #10 | Frigerio Fabio | 8 |
| Publication | Filing date | Title |
|---|---|---|
| GB201811452D0 | P2X3 receptor antagonists | |
| EP3308773A1 | Formulations of cysteamine and cysteamine derivatives |